Afshar, M., Williams, C., Parmentier, F., Etcheto, A. & Missling, C. U. Gut Microbiota and Response to Blarcamesine (ANAVEX®2-73) in Alzheimer’s Disease Patients : Abundance of Lachnospiraceae and Enterobacteriaceae Families as Potential Biomarker of Response from a 2-Year Study Interim Clinical Data Analysis using KEM ® Arti. Clin. Trials Alzheimer’s Dis. Conf. 2019 73 (2019).
Afshar, M., Williams, C., Sritharan, N., Etcheto, A. & Missling, C. U. Novel analytics framework for augmenting single-arm Phase 2a open label trials with Real-World external control data: Application to the Blarcamesine (ANAVEX®2-73) study in Alzheimer’s disease matched with propensity corrected patients from Alzheimer’s Di. Clin. Trials Alzheimer’s Dis. Conf. 2019 6, 1–44 (2019).